This is related to the fact that FKBP51 is an interacting partner of deleted in liver ancer-1 and -2 proteins (DLC-1 and -2 proteins), Rho GTPase-activating proteins that are frequently downregulated in various types of cancer. This evidence concerns the gene FKBP5 and cancer.